GT Biopharma (GTBP) Market Capitalization (2010 - 2026)

GT Biopharma (GTBP) has reported Market Capitalization for 17 consecutive years, with $574309.3 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Market Capitalization rose 163.29% year-over-year to $574309.3 in Q1 2026; TTM through Mar 2026 was $574309.3, a 163.29% increase from a year earlier, with the FY2025 full-year figure at $173160.2, down 36.48% from the prior year.
• Market Capitalization was $574309.3 for Q1 2026 at GT Biopharma, up from $173160.2 in the prior quarter.
• Over five years, Market Capitalization peaked at $3.7 million in Q1 2022 and troughed at $92449.4 in Q3 2025.
• A 5-year average of $907553.4 and a median of $422471.3 in 2023 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization plunged 86.18% in 2023 and surged 163.29% in 2026, its largest moves.
• Over 5 years, Market Capitalization stood at $1.2 million in 2022, then tumbled by 63.55% to $422471.3 in 2023, then plunged by 35.48% to $272587.6 in 2024, then sank by 36.48% to $173160.2 in 2025, then surged by 231.66% to $574309.3 in 2026.
• The last three Market Capitalization figures came in at $574309.3 (Q1 2026), $173160.2 (Q4 2025), and $92449.4 (Q3 2025), per Business Quant data.